Skip to main content
Smart Investors Daily
Nuo Therapeutics, Inc. logo

OTC · AURX

Nuo Therapeutics, Inc.

Healthcare · Biotechnology

$1.30

Up+$0.00 (+0.00%)

Updated Oct 10, 2026, 2:21 PM

SID Score

3.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
100.96M
P/E ratio
-41.08
Dividend yield
0.00%
52-week range
$0.77 – $3.23
Volume
6.5K
Avg. volume
3.73K

Price performance · AURX

AURX price history

1M range · 13 trading sessions · Daily adjusted prices

Prices through Oct 9, 2026

AURX closed at $1.30 after 13 trading sessions, up 4.00% for the selected period.

Last close
$1.30
Period change
+4.00%
Period low
$1.24
Period high
$1.32
Daily close
View OHLC price history
AURX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 9, 2026$1.30$1.30$1.30$1.306.5K
Oct 7, 2026$1.30$1.30$1.30$1.303.75K
Oct 6, 2026$1.30$1.30$1.30$1.30244
Sep 30, 2026$1.25$1.25$1.25$1.25200
Sep 29, 2026$1.304$1.304$1.25$1.25841
Sep 28, 2026$1.32$1.32$1.32$1.32800
Sep 25, 2026$1.265$1.265$1.25$1.2510.01K
Sep 23, 2026$1.25$1.2829$1.25$1.28294.2K
Sep 18, 2026$1.25$1.30$1.25$1.302.1K
Sep 17, 2026$1.27$1.27$1.20$1.24014.04K
Sep 16, 2026$1.26$1.26$1.26$1.265K
Sep 15, 2026$1.26$1.26$1.26$1.262.19K
Sep 11, 2026$1.281$1.281$1.25$1.25600

Latest AURX news

The latest Smart Investors Daily articles mentioning AURX.

AURX research

Overview

Company profile and research snapshot.

Company profile

NUO THERAPEUTICS INC NEW

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
AURX recent ratings
DateFirmRatingTarget
Dec 16, 2025Roth CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.